<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[A new clinical trial protocol investigates a four-part combination therapy for thirty-four patients with advanced hepatocellular carcinoma who cannot undergo ...]]></title><description><![CDATA[<p>A new clinical trial protocol investigates a four-part combination therapy for thirty-four patients with advanced hepatocellular carcinoma who cannot undergo ...</p><p><a href="https://www.bioscience.com.pk/en/subject/medicine/efficacy-and-safety-of-hepatic-arterial-infusion-chemotherapy-combined-with-palliative-transarterial-chemoembolization-followed-by-targeted-therapy-and-immunotherapy-in-patients-with-bclc-stage-c-hepatocellular-carcinoma-clinical-trial-protocol" rel="nofollow noopener"><span>https://www.</span><span>bioscience.com.pk/en/subject/m</span><span>edicine/efficacy-and-safety-of-hepatic-arterial-infusion-chemotherapy-combined-with-palliative-transarterial-chemoembolization-followed-by-targeted-therapy-and-immunotherapy-in-patients-with-bclc-stage-c-hepatocellular-carcinoma-clinical-trial-protocol</span></a></p><p><a href="https://mastodon.social/tags/Medicine" rel="tag">#<span>Medicine</span></a> <a href="https://mastodon.social/tags/MedicalScience" rel="tag">#<span>MedicalScience</span></a> <a href="https://mastodon.social/tags/Health" rel="tag">#<span>Health</span></a></p>]]></description><link>https://postcall.pub/topic/4f9bebb4-93e6-48cb-a86c-05ed20803b29/a-new-clinical-trial-protocol-investigates-a-four-part-combination-therapy-for-thirty-four-patients-with-advanced-hepatocellular-carcinoma-who-cannot-undergo-...</link><generator>RSS for Node</generator><lastBuildDate>Sun, 22 Nov 2026 22:25:59 GMT</lastBuildDate><atom:link href="https://postcall.pub/topic/4f9bebb4-93e6-48cb-a86c-05ed20803b29.rss" rel="self" type="application/rss+xml"/><pubDate>Sat, 21 Nov 2026 15:50:51 GMT</pubDate><ttl>60</ttl></channel></rss>